Anhui Fengyuan Pharmaceutical Co., Ltd. (000153) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Anhui Fengyuan Pharmaceutical Co., Ltd.

Why is Anhui Fengyuan Pharmaceutical Co., Ltd. ?

High Debt Company with a Debt to Equity ratio (avg) at times

Poor long term growth as Net Sales has grown by an annual rate of 4.32% and Operating profit at 2.92% over the last 5 years
High Debt Company with a Debt to Equity ratio (avg) at times
The company has been able to generate a Return on Equity (avg) of 7.81% signifying low profitability per unit of shareholders funds

Poor long term growth as Net Sales has grown by an annual rate of 4.32% and Operating profit at 2.92% over the last 5 years

With a fall in Net Sales of -8.59%, the company declared Very Negative results in Mar 25

The company has declared negative results for the last 5 consecutive quarters
OPERATING CASH FLOW(Y) Lowest at CNY 132.05 MM
INTEREST COVERAGE RATIO(Q) Lowest at 541.7
NET PROFIT(9M) At CNY 92.19 MM has Grown at -20.86%

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Anhui Fengyuan Pharmaceutical Co., Ltd. for you?

Medium Risk, Medium Return

Absolute

Risk Adjusted

Volatility

Anhui Fengyuan Pharmaceutical Co., Ltd.

2.72%

0.77

29.97%

China Shanghai Composite

15.19%

1.01

15.10%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

4.32%

EBIT Growth (5y)

2.92%

EBIT to Interest (avg)

4.90

Debt to EBITDA (avg)

2.86

Net Debt to Equity (avg)

0.54

Sales to Capital Employed (avg)

1.38

Tax Ratio

20.12%

Dividend Payout Ratio

28.89%

Pledged Shares

Institutional Holding

ROCE (avg)

6.31%

ROE (avg)

7.81%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

1.36

EV to EBIT

31.56

EV to EBITDA

14.27

EV to Capital Employed

1.23

EV to Sales

1.00

PEG Ratio

Dividend Yield

1.57%

ROCE (Latest)

3.91%

ROE (Latest)

5.94%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bearish

Mildly Bullish

RSI

No Signal

Bollinger Bands

Bullish

Moving Averages

Bullish (Daily)

KST

Mildly Bearish

Bullish

Dow Theory

Mildly Bearish

No Trend

OBV

Mildly Bullish

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

0What is working for the Company

NO KEY POSITIVE TRIGGERS

-23What is not working for the Company

OPERATING CASH FLOW(Y)

Lowest at CNY 132.05 MM

INTEREST COVERAGE RATIO(Q)

Lowest at 541.7

NET PROFIT(9M)

At CNY 92.19 MM has Grown at -20.86%

ROCE(HY)

Lowest at 7.58%

NET SALES(Q)

At CNY 932.87 MM has Fallen at -16.07%

INTEREST(Q)

At CNY 8.34 MM has Grown at 13.84%

RAW MATERIAL COST(Y)

Grown by 13.57% (YoY

CASH AND EQV(HY)

Lowest at CNY 478.61 MM

DEBT-EQUITY RATIO (HY)

Highest at 54.25 %

DEBTORS TURNOVER RATIO(HY)

Lowest at 3.71%

PRE-TAX PROFIT(Q)

Fallen at -37.24%

Here's what is not working for Anhui Fengyuan Pharmaceutical Co., Ltd.

Interest Coverage Ratio

Lowest at 541.7 and Fallen

In each period in the last five periods

MOJO Watch

The company's ability to manage interest payments is deteriorating

Operating Profit to Interest

Operating Cash Flow

Lowest at CNY 132.05 MM and Fallen

In each year in the last three years

MOJO Watch

The company's cash revenues from business operations are falling

Operating Cash Flows (CNY MM)

Net Sales

At CNY 932.87 MM has Fallen at -16.07%

Year on Year (YoY)

MOJO Watch

Near term sales trend is very negative

Net Sales (CNY MM)

Interest

At CNY 8.34 MM has Grown at 13.84%

period on period (QoQ)

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Net Profit

At CNY 92.19 MM has Grown at -20.86%

Year on Year (YoY)

MOJO Watch

Near term Net Profit trend is negative

Net Profit (CNY MM)

Net Sales

Lowest at CNY 932.87 MM

in the last five periods

MOJO Watch

Near term sales trend is negative

Net Sales (CNY MM)

Interest

Highest at CNY 8.34 MM

in the last five periods and Increased by 13.84% (QoQ)

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Pre-Tax Profit

Fallen at -37.24%

Year on Year (YoY)

MOJO Watch

Near term Pre-Tax Profit trend is negative

Pre-Tax Profit (CNY MM)

Cash and Eqv

Lowest at CNY 478.61 MM

in the last six Semi-Annual periods

MOJO Watch

Short Term liquidity is deteriorating

Cash and Cash Equivalents

Debt-Equity Ratio

Highest at 54.25 %

in the last five Semi-Annual periods

MOJO Watch

The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Debtors Turnover Ratio

Lowest at 3.71%

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling Debtors has slowed

Debtors Turnover Ratio

Raw Material Cost

Grown by 13.57% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales